Skip to main content

Harold Moses Archives

15 faculty members elected as AAAS fellows

Nov. 20, 2017—Fifteen Vanderbilt faculty members conducting a range of biomedical and clinical research have been elected fellows of the American Association for the Advancement of Science. Six of the 15 have received funding through the university’s Trans-Institutional Programs initiative, which facilitates research and teaching collaborations across disciplines and are a core pillar of the university’s Academic Strategic Plan.

Read more


Symposium honors Moses’ storied cancer research career

Oct. 19, 2017—Members of the Vanderbilt University Medical Center (VUMC) community and others whose lives and careers have been influenced by legendary cancer investigator, educator and administrator Harold (Hal) Moses, M.D., have endowed the Linda and Harold L. Moses, M.D. Career Development Fund.

Read more


Special symposium to honor Moses’ cancer research contributions is Oct. 11

Sep. 21, 2017—A research symposium honoring the career of Harold (Hal) Moses, M.D., who founded and served as director emeritus of Vanderbilt-Ingram Cancer Center, has been slated for Wednesday, Oct. 11, 7:45 a.m. – 3:30 p.m., at the Vanderbilt Student Life Center.

Read more


Moses elected to National Academy of Inventors

Dec. 16, 2016—Harold (Hal) Moses, M.D., Ingram Professor of Cancer Research and director emeritus of Vanderbilt-Ingram Cancer Center (VICC), has been named a Fellow of the National Academy of Inventors (NAI). Moses, professor and interim chair of Cancer Biology, is among 175 academic leaders named to the 2016 class of NAI Fellows.

Read more


Vanderbilt mourns loss of philanthropist Tony Martell

Dec. 7, 2016—Members of the Vanderbilt community are mourning the loss of music executive and health care philanthropist Tony Martell, who died Sunday, Nov. 27, at his home in New Jersey. He was 90.

Read more


IOM study calls for better evidence for biomarker tests

Mar. 10, 2016—Biomarker tests that help determine which patients may benefit from molecularly targeted therapies need better evidence and oversight to improve their effectiveness and availability, according to a study by the Institute of Medicine (IOM) of the National Academies of Sciences, Engineering, and Medicine.

Read more


New lead for ovarian cancer treatment

Dec. 10, 2015—Combining inhibitors of the BMP signaling pathway with standard chemotherapy drugs may overcome drug resistance in ovarian cancer.

Read more


Moses, Shyr named to Institute of Medicine cancer therapies panel

Mar. 5, 2015—Two Vanderbilt-Ingram Cancer Center (VICC) leaders have been named to a panel of the Institute of Medicine (IOM) to help shape national policies on the use of biomarkers for targeted cancer therapies.

Read more


BlackHawk’s Cancer Center support reaches milestone

Feb. 12, 2015—Country music group BlackHawk recently presented a check for $20,000 to Harold (Hal) Moses, M.D., Ingram Professor of Cancer Research and director emeritus of Vanderbilt-Ingram Cancer Center (VICC), in support of cancer research.

Read more


Growth factor blockade targets breast tumors

Aug. 14, 2014—Inhibition of BMP growth factor signaling reduces breast tumor burden and metastasis.

Read more


Impact of philanthropy drives faculty members

Aug. 7, 2014—For Vanderbilt faculty members Vivien Casagrande, Ph.D., Hal Moses, M.D., and Paul Sternberg Jr., M.D., the lessons about the importance of giving came early.

Read more


Moses to receive Vanderbilt Distinguished Alumni Award

Jan. 20, 2014—Harold “Hal” Moses, the Hortense B. the Ingram Professor of Cancer Research at Vanderbilt University, is the recipient of the 2014 Distinguished Alumni Award — the highest honor for a member of the Vanderbilt alumni community.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more